Description
BSE announces listing of 9,32,384 new equity shares of Trident Texofab Limited issued through warrant conversion, effective August 4, 2025.
Summary
BSE has announced the listing of 9,32,384 new equity shares of Trident Texofab Limited (Scrip Code: 540726) effective from Monday, August 4, 2025. These shares were issued at a premium of Rs. 60/- per share to non-promoters on preferential basis pursuant to warrant conversion.
Key Points
- 9,32,384 equity shares of Rs. 10/- each listed
- Issue price: Rs. 70/- (Rs. 10 face value + Rs. 60 premium)
- Issued to non-promoters on preferential basis
- Shares rank pari-passu with existing equity shares
- ISIN: INE071Y01013
- Distribution numbers: 14063381 to 14995764
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
Trading members are informed of the new securities listing and permitted trading from the effective date.
Important Dates
- Allotment Date: 29/05/2025 (4,50,477 shares) and 04/06/2025 (4,81,907 shares)
- Trading Commencement: Monday, August 4, 2025
- Lock-in Period: Until February 5, 2026
Impact Assessment
Minimal market impact as this is a routine listing of new securities through warrant conversion. The lock-in period until February 2026 ensures these shares cannot be traded immediately, limiting any dilution effect.
Impact Justification
Routine new securities listing with limited market impact